Clostridioides difficile Toxins and Virulence Factors

A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".

Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 5146

Special Issue Editor


E-Mail Website
Guest Editor
Center for Infectious Diseases, Department of Epidemiology, Human Genetics & Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, 7000 Fannin St. Suite 600, Houston, TX 77030, USA
Interests: infectious diseases; mechanisms of host-pathogen interactions; antimicrobial resistance; host genetics; susceptibility to bacterial infections
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Clostridioides (formerly Clostridium difficile) infection (CDI) is a major public health problem worldwide. CDI incidence rates are increasing at an alarming rate, with the total cost of treatment estimated to be up to 7 billion US dollars annually. C. difficile is responsible for 10%–25% of cases of antibiotic-associated diarrhea, 50%–75% of antibiotic-associated colitis, and 90%–100% of pseudomembranous colitis. Morbidity and mortality resulting from CDI-associated diseases have also increased significantly over the past ten years, making C. difficile one of the most important emerging antibiotic-associated diarrheagenic pathogens in the world. As a result, the U. S. Centers for Disease Control and Prevention has designated C. difficile as an urgent threat. The risk for CDI increases with broad-spectrum antibiotics use, which disrupts the native gut microbiota, allowing C. difficile to proliferate. Other CDI-associated risk factors include old age, use of gastric acid-suppressing drugs, comorbidities, immunodeficiency, and inflammatory bowel disease. C. difficile virulence is largely dependent on the production of the toxins which are directly responsible for the disease. This Special Issue will cover recent findings on C. difficile toxins, as well as important virulence factors involved in its pathogenesis.

Prof. Dr. Charles Darkoh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Clostridium difficile pathogenesis
  • Clostridium toxins A and A
  • Clostridium binary toxins
  • virulence factors of Clostridium
  • toxin regulation

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

13 pages, 916 KiB  
Review
An Update on Clostridioides difficile Binary Toxin
by Adrián Martínez-Meléndez, Flora Cruz-López, Rayo Morfin-Otero, Héctor J. Maldonado-Garza and Elvira Garza-González
Toxins 2022, 14(5), 305; https://0-doi-org.brum.beds.ac.uk/10.3390/toxins14050305 - 27 Apr 2022
Cited by 15 | Viewed by 4656
Abstract
Infection with Clostridioides difficile (CDI), a common healthcare-associated infection, includes symptoms ranging from mild diarrhea to severe cases of pseudomembranous colitis. Toxin A (TcdA) and toxin B (TcdB) cause cytotoxicity and cellular detachment from intestinal epithelium and are responsible for CDI symptomatology. Approximately [...] Read more.
Infection with Clostridioides difficile (CDI), a common healthcare-associated infection, includes symptoms ranging from mild diarrhea to severe cases of pseudomembranous colitis. Toxin A (TcdA) and toxin B (TcdB) cause cytotoxicity and cellular detachment from intestinal epithelium and are responsible for CDI symptomatology. Approximately 20% of C. difficile strains produce a binary toxin (CDT) encoded by the tcdA and tcdB genes, which is thought to enhance TcdA and TcdB toxicity; however, the role of CDT in CDI remains controversial. Here, we focused on describing the main features of CDT and its impact on the host, clinical relevance, epidemiology, and potential therapeutic approaches. Full article
(This article belongs to the Special Issue Clostridioides difficile Toxins and Virulence Factors)
Show Figures

Figure 1

Back to TopTop